Navigating the Web of the Prescription Approval and Appeals Process: A Case Study with PCSK9i | VuMedi

Cardiometabolic Health Congress (CMHC)

Navigating the Web of the Prescription Approval and Appeals Process: A Case Study with PCSK9i

By Cardiometabolic Health Congress (CMHC) FEATURING Matthew Stryker

By Cardiometabolic Health Congress (CMHC) FEATURING Matthew Stryker

124 views

October 22, 2019

0 Comments

Login to view comments. Click here to Login

Featured Video

Featured Video

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

22.0K views

Basic Accounting for Physicians: What Skills Do You Need to Have to …

Codman Shoulder Society

J. Warner

21.6K views

Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

15.2K views

Recent Cholesterol Guidelines and Integration into Clinical Practice

The North American Thrombosis Forum (NATF)

J. Plutzky, L. Braun, J. Ross

14.4K views

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

13.1K views

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

11.6K views

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

10.6K views

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

10.8K views

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

8.5K views

How Do I Reverse Coronary Plaque?

Scripps Health

C. J. Suhar

7.0K views

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "Go as…

ACC 2022 Conference Coverage

R. Giugliano

6.4K views

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

The Texas Heart Institute

S. Virani

5.5K views

I Ordered an Lp(a) Level – Now What?

Canadian Collaborative Research Network

M. O'Donoghue

4.1K views

VICTORION-INITIATE – Comparing Inclisiran First to Usual Care in Pat…

Canadian Collaborative Research Network

M. Gupta

158 views

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

Jefferson Health

A. Cohen

4.1K views

Big Questions About Lipoprotein “Little” (a)

MUSC Cardiology

A. Arana Waring

3.2K views

How to Reduce Cholesterol and Triglycerides to Prevent CV Events

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

P. Taub

4.8K views

ACC 2024 Insights: Measure Lp(a) in All Patients Once: One & Done!

ACC 2024 Insights

S. Mora

3.5K views

Update on Lipoprotein A: The Horrible Cholesterol

Norman Lepor

4.0K views

Do Statins Prevent or Cause Heart Disease? Should LDL Be Called "Bad…

Nadir Ali

3.9K views